You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

August 8, 2024

Thailand Updates Food Labeling Requirements

On July 19, 2024, Thailand’s Ministry of Public Health Notification No. 450 B.E.2567 (2024) came into effect after being published in the Government Gazette the day before. The notification introduces significant updates to the labeling requirements for prepackaged foods. This new regulation consolidates and updates Thailand’s rules for food labeling by repealing and replacing several previous notifications.

The notification’s key changes and their implications for food businesses are identified below.

1. Clarified “Best Before” Definition

The notification aligns the definition of “best before” with Codex standards. It now refers to the date marking the end of the period during which the food maintains its best quality under stated storage conditions. After this date, food quality may change, and the product cannot be marketed.

2. Updated Labeling Exceptions

Certain foods are exempt from labeling requirements, with the latest list including:

  • Foods sold directly to consumers by manufacturers who can provide product information.
  • Unprocessed foods.
  • Some fresh foods not sold directly to consumers.
  • Prepackaged foods produced and sold for immediate consumption in food service settings.

However, any of these exempt foods that have received food serial numbers must still have labels that comply with the notification.

3. Expiration Date and Best-Before Date Display

The notification provides clearer language for displaying the expiration date and best-before date. If specific wording is required by other notifications, it must be followed. English equivalents are now permitted alongside Thai text.

4. Warning Displays

Multiple applicable warnings can now be consolidated and displayed together, provided the complete message is included as specified.

5. Claims about Substances or Ingredients

New guidelines have been established for making claims about food additives and ingredients. Claims should be factual, not deceptive, and provably not false.

6. Label Placement and Design

Labels must be permanently affixed, proportionate to the packaging, and prominently displayed.

7. Display of Trademarks

Symbols related to trademarks or registered trademarks can be displayed with English symbols or text instead of Thai symbols or text.

8. Changes to Miscellaneous Requirements

The notification also includes changes to various labeling requirements:

  • Additional information beyond the specified requirements is now allowed, provided it does not mislead consumers.
  • For foods where net weight cannot be displayed, units (e.g., number of eggs) must be used instead.
  • The ingredient list no longer needs to be in descending order by weight, as this is now only a recommendation.
  • Shellfish, squid, and their products have been added to the Thai FDA’s list of allergens that need to be clearly identified when applicable.
  • Food coloring additives no longer need to be specified as natural or synthetic.
  • Food names no longer need to be displayed in a horizontally continuous manner.

Compliance Timeline

Food products labeled before July 19, 2024, can continue to be sold for up to two years from this date. However, businesses should begin transitioning to the new labeling requirements as soon as possible to ensure full compliance by July 19, 2026.

Recommendations for Food Businesses

This notification on labeling for prepackaged foods contains a number of notable updates and changes. In order to stay compliant with the latest regulations, companies with affected products should:

  • Review current labeling practices against the new requirements.
  • Update labeling designs and information to comply with the new regulations.
  • Notify staff of the new requirements, particularly regarding allergen information and expiration date displays.
  • Ensure any claims made about substances or ingredients meet the new guidelines.

Companies may also wish to adjust their labeling strategies to take advantage of the various flexibilities introduced by the new notification.

RELATED INSIGHTS​ 

June 9, 2021
The latest updates to Practical Law’s Life Sciences Global Guide feature two revised sections from Tilleke & Gibbins attorneys in the firm’s Jakarta office—“Medicinal Product Regulation and Product Liability in Indonesia,” and “Pharmaceutical IP and Competition Law in Indonesia.” “Medicinal Product Regulation and Product Liability in Indonesia” covers a range of regulatory issues related to the marketing and selling of pharmaceutical products, including the following: Regulatory overview, including relevant laws and authorities, scope, definitions, and general procedures for pharmaceuticals, biologicals, and medical devices and health care IT Pricing, government funding, and reimbursement: Structure of Indonesia’s health care system, price regulation, and reimbursement Clinical trials Manufacturing and distribution Marketing: Authorization for marketing medicinal products, parallel imports and cross-border trade in medicines Restrictions on dealings with health care professionals Selling restrictions Advertising and promotion Data privacy Packaging, labeling, and tracking Product safety, quality, and liability Local establishment, representation, and residency requirements Reform The full “Medicinal Product Regulation and Product Liability in Indonesia” section can be accessed on the Practical Law website. “Pharmaceutical IP and Competition Law in Indonesia” first goes over the country’s legal and regulatory environment for patents and trademarks in relation to pharmaceutical business operations in the jurisdiction. The section then turns to competition law issues, with the Q&A format focusing on how the country’s competition laws and regulations affect the pharmaceutical sector. Readers are also given information on how to properly comply with Indonesian competition law, including in the licensing of medicines and pharmaceutical technology. The full “Pharmaceutical Intellectual Property and Competition Law in Indonesia” section can be found on the Practical Law website. Practical Law, produced by Thomson Reuters, is the world’s leading legal know-how resource for business lawyers, publishing a huge range of guides covering hundreds of jurisdictions and practice areas.
May 27, 2021
The new regulations for using Indonesia’s SIAPIK system have the potential to affect companies’ advertising plans and help maintain the relevance and effectiveness of Indonesia’s drug advertising regulatory environment